MWG Biotech has launched its MWG Human 40K Array, which comprises 40,000 human genes on two microarray slides. The 40K A Array has 20,000 genes with “full functional characterization and content referencing,” and the 40K B Array has whose 20,000 genes that are referenced against “several” NCBI databases.
MWG said 21 Gene Ontology-based functional groups, which are located in 384-well plates, were created for the Human 40K Array, whose groups reside in 384-well plates. MWG used its Oligos4Arrays software to design the gene-specific 50-mer oligonucleotides used on the Human 40K Array.
Qiagen has launched Epoch Biosciences’ QuantiTect custom gene-expression assays and probe and primer sets for quantitative real-time PCR based on Epoch’s MGB Eclipse technology.
The assays were developed by integrating Epoch’s software and Qiagen’s web-based ordering. In November 2002, the companies penned a marketing agreement that gave Qiagen co-exclusive worldwide sales and marketing rights to products incorporating Epoch’s MGB Eclipse probe systems. Terms of that deal called for Qiagen to receive a license to the component technologies, and for Epoch to receive access fees and royalties.